FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> vaccine safety | H1N1

H1N1 vax monitoring flags potential risks

Tools

The CDC says that their monitoring programs have uncovered a very small increased risk for Guillain-Barre syndrome, Bell's palsy and thrombocytopenia among people who were injected with the H1N1 vaccine. But the increased risk is so small, the CDC says it can't tell if the apparent increase in danger is the result of a problem with the vaccine or simply the result of better monitoring. "Because the effects are so small, it is hard to say whether it is due to chance or a real effect," said Dr. Stephen Redd, director of the CDC's influenza coordination unit. Story


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about vaccine safety   H1N1  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.